Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
Abstract The ability of TNP‐470, a synthetic analog of fumagillin which has been described as an anti‐angiogenic agent, to potentiate cytotoxic cancer therapies was investigated...